Published by Benjamin Chiou on 6th August 2014
Shire, the pharmaceutical group which has agreed to a £32bn takeover by Abbvie, saw its shares decline sharply on Wednesday on concerns that stricter rules on so-called 'tax inversion' in the States could scupper the deal.
URL: http://www.digitallook.com/dl/news/story/21938347/...